PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS

被引：0
|
作者：
Nishimura, Noriyuki [1 ]
Ishida, Toshiaki [2 ]
Yokota, Isao [2 ]
Matsumoto, Kimikazu [2 ]
Shichino, Hiroyuki [2 ]
Kamijo, Takehiko [2 ]
Takimoto, Tetsuya [2 ]
Iehara, Tomoko [2 ]
Tajiri, Tatsuro [2 ]
机构：
[1] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan
[2] Japan Childrens Canc Grp JCCG Neuroblastoma Comm, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS2-1
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Minimal Residual Disease Detected by the 7NB-mRNAs ddPCR Assay Is Associated with Disease Progression in High-Risk Neuroblastoma Patients: A Prospective Multicenter Observational Study in Japan
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Yokota, Isao
    Matsumoto, Kimikazu
    Shichino, Hiroyuki
    Fujisaki, Hiroyuki
    Sarashina, Takeo
    Kamijo, Takehiko
    Takimoto, Tetsuya
    Iehara, Tomoko
    Tajiri, Tatsuro
    BIOLOGY-BASEL, 2023, 12 (10):
  • [2] Detection of minimal residual disease in high-risk neuroblastoma patients by digital PCR
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Uemura, Suguru
    Yamamoto, Nobuyuki
    Hasegawa, Daiichiro
    CANCER SCIENCE, 2018, 109 : 1113 - 1113
  • [3] Detection and treatment of minimal residual disease in high-risk neuroblastoma
    Reynolds, CP
    PEDIATRIC TRANSPLANTATION, 2004, 8 : 56 - 66
  • [4] Quantitation of Minimal Residual Disease by Droplet Digital PCR in High-Risk Neuroblastoma Patients
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Thwin, Khin
    Uemura, Suguru
    Yamamoto, Nobuyuki
    Tamura, Akihiro
    Nino, Nanako
    Kozaki, Aiko
    Saito, Atsuro
    Kishimoto, Kenji
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Takafuji, Satoru
    Mori, Takeshi
    Iijima, Kazumoto
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S38 - S39
  • [5] Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma
    Reynolds, CP
    Seeger, RC
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (03) : 150 - 152
  • [6] Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma
    Aschero, Rosario
    Castillo-Ecija, Helena
    Baulenas-Farres, Merce
    Resa-Pares, Claudia
    Jimenez-Cabaco, Ana
    Rodriguez, Eva
    Monterrubio, Carles
    Perez-Jaume, Sara
    Sunol, Mariona
    Chantada, Guillermo L.
    Lavarino, Cinzia
    Mora, Jaume
    Carcaboso, Angel M.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (06)
  • [7] Minimal Residual Disease in Peripheral Blood Stem Cell Harvests From High-risk Neuroblastoma Patients
    Avigard, Smadar
    Feinberg-Gorenshtein, Galina
    Luria, Dorit
    Jeison, Marta
    Stein, Jerry
    Grunshpan, Anna
    Sverdlov, Yacov
    Ash, Shifra
    Yaniv, Issac
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (01) : 22 - 26
  • [8] Prognostic Values of Tumor Markers and Minimal Residual Disease Detected by 7NB-mRNAs ddPCR Assay for High-Risk Neuroblastoma Patients
    Uemura, Suguru
    Ishida, Toshiaki
    Kyaw, Sanlin
    Nakatani, Naoko
    Nino, Nanako
    Yamamoto, Nobuyuki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Iijima, Kazumoto
    Nishimura, Noriyuki
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [9] Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients
    Hirase, Satoshi
    Saitoh, Atsuro
    Hartomo, Tri Budi
    Kozaki, Aiko
    Yanai, Tomoko
    Hasegawa, Daiichiro
    Kawasaki, Keiichiro
    Kosaka, Yoshiyuki
    Matsuo, Masafumi
    Yamamoto, Nobuyuki
    Mori, Takeshi
    Hayakawa, Akira
    Iijima, Kazumoto
    Nishio, Hisahide
    Nishimura, Noriyuki
    ONCOLOGY LETTERS, 2016, 12 (02) : 1119 - 1123
  • [10] Comment on: Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma
    Saleem, Yusra M.
    Dar, Marrium Sultan
    Kumar, Satesh
    PEDIATRIC BLOOD & CANCER, 2023, 70 (10)
12345